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Directs Neural Crest But Not Placodal Lineage EGFP
Expression in a Transgenic Animal
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Section on Transmitter Signaling, Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health,
Bethesda, Maryland 20892-9411
Under physiological conditions, the voltage-gated sodium channel Nav1.8 is expressed almost exclusively in primary sensory neurons.
The mechanism restricting Nav1.8 expression is not entirely clear, but we have previously described a 3.7 kb fragment of the Scn10a
promoter capable of recapitulating the tissue-specific expression of Nav1.8 in transfected neurons and cell lines (Puhl and Ikeda, 2008).
To validate these studies in vivo, a transgenicmouse encoding EGFP under the control of this putative sensory neuron specific promoter
was generated and characterized in this study. Approximately 45% of dorsal root ganglion neurons of transgenic mice were EGFP-
positive (mean diameter 26.5m). The majority of EGFP-positive neurons bound isolectin B4, although a small percentage (10%)
colabeled with markers of A-fiber neurons. EGFP expression correlated well with the presence of Nav1.8 transcript (95%), Nav1.8-
immunoreactivity (70%), and TTX-R INa (100%), although not all Nav1.8-expressing neurons expressed EGFP. Several cranial sensory
ganglia originating fromneurogenic placodes, such as the nodose ganglion, failed to express EGFP, suggesting that additional regulatory
elements dictate Scn10a expression in placodal-derived sensory neurons. EGFP was also detected in discrete brain regions of transgenic
mice. Quantitative PCR and Nav1.8-immunoreactivity confirmed Nav1.8 expression in the amygdala, brainstem, globus pallidus, lateral
and paraventricular hypothalamus, and olfactory tubercle. TTX-R INa recorded fromEGFP-positive hypothalamic neurons demonstrate
the usefulness of this transgenic line to study novel roles of Nav1.8 beyond sensory neurons. Overall, Scn10a-EGFP transgenic mice
recapitulate the majority of the Nav1.8 expression pattern in neural crest-derived sensory neurons.
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Introduction
Voltage-gated sodium channels (VGSCs) are largely responsible
for generating and propagating action potentials in neurons and
other excitable cells. The pore-forming  subunit of VGSC,
which is260 kDa in mass, consists of four domains each com-
posed of six transmembrane helices (Catterall, 2000). Ninemem-
bers of themammalian subunit (Nav1.1–1.9) and four auxiliary
 subunits (1–4) have been identified.
The expression profile of the various  subunit family mem-
bers often overlaps, although somemembers are expressed exclu-
sively in discrete locations. For instance, Nav1.8 is expressed in a
subset of primary afferent neurons of which85% are nocicep-
tors (Akopian et al., 1999; Djouhri et al., 2003). The restricted
expression profile in a subpopulation of DRG neurons has made
the gene encoding Nav1.8, Scn10a, an attractive target for nocice-
ptor specific gene deletion. Knock-in mouse lines developed us-
ing the Cre-loxP system, where Cre recombinase expression is
under the control of the endogenous Scn10a promoter (Agarwal
et al., 2004; Nassar et al., 2004), are available and have been a
valuable tool to knock-out genes exclusively in nociceptive neu-
rons (Nassar et al., 2004, 2005; Abrahamsen et al., 2008) and to
study Nav1.8-expressing cells within a heterogeneous DRG pop-
ulation (Gautron et al., 2011; Shields et al., 2012a). Of note, both
Nav1.8-Cre mouse lines exhibit slight differences in expression
profiles, specifically in the spinal cord, brain, and outside the
nervous system.
As useful as Nav1.8 knock-in mouse lines have become, the
mechanism underlying the tight transcriptional regulation of
Scn10a remains unclear. To help resolve the regulatory elements
responsible for controlling Scn10a gene expression, we cloned the
promoter and assessed tissue-specific promoter activity in vitro
(Puhl and Ikeda, 2008). In the study, we identified a 3.7 kb seg-
ment of the Scn10a promoter that recapitulated the restricted
expression pattern of Nav1.8 in a subpopulation of DRG but not
Received Jan. 15, 2015; revised April 17, 2015; accepted April 22, 2015.
Author contributions: V.B.L. and H.L.P. designed research; V.B.L., S.R.I., and H.L.P. performed research; S.R.I.
contributed unpublished reagents/analytic tools; V.B.L. and H.L.P. analyzed data; V.B.L., S.R.I., and H.L.P. wrote the
paper.
This work was supported by the Intramural program at the National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism. We thank Dr. James Pickel (National Institute of Mental Health Transgenic Core
Facility) for assistancewith pronuclearmicroinjections and Dr. Margaret Davis (Laboratory for Integrative Neurosci-
ence/National Institute on Alcohol Abuse and Alcoholism) for technical assistance with immunohistochemistry
experiments.
The authors declare no competing financial interests.
Correspondence should be addressed to Dr. Henry L. Puhl, III, Laboratory of Molecular Physiology, National
Institutes of Health/National Institute on Alcohol Abuse and Alcoholism, 5625 Fishers Lane, Room TS-06, Rockville,
MD 20852. E-mail: puhlh@mail.nih.gov.
DOI:10.1523/JNEUROSCI.0214-15.2015
Copyright © 2015 the authors 0270-6474/15/358021-14$15.00/0
The Journal of Neuroscience, May 20, 2015 • 35(20):8021–8034 • 8021
sympathetic neurons. To validate and extend these studies to an
in vivo model, we generated a transgenic mouse line with EGFP
under the transcriptional regulation of this putative Scn10a pro-
moter region.
In Scn10a-EGFP transgenic mice, we found EGFP expression
restricted to a subpopulation of primary afferent cell bodies and
terminals. Specifically, the EGFP-positive DRG population cor-
responded with the small- to medium-sized neuronal popula-
tion, but a small proportion of A-fiber DRG neurons were also
EGFP-positive. However, transgene expression was limited to
neural crest-derived sensory neurons because EGFP expression
was not found in the nodose ganglion or other ganglia of placodal
origin. We also found EGFP and functional Nav1.8 expression in
theCNS,whichmay be indicative of a novel role ofNav1.8 inCNS
function and excitability. Thus, the Scn10a-EGFP mouse line
generated and characterized in this study is a useful tool to iden-
tify Nav1.8-expressing neural crest-derived neurons and study
the regulatory elements responsible for the restrictive expression
of Nav1.8.
Materials andMethods
Transgenic mouse generation
All animal studies were conducted in accordance to the National Insti-
tutes of Health’s Guidelines for Animal Care and Use.
Transgenicmicewere generated by pronuclear injection of a linearized
DNA construct consisting of the putative promoter region of Scn10a, a
3.7 kb sequence immediately upstream of the transcriptional start site of
the Scn10a gene, and the EGFP sequence (see Fig. 1A). Injected oocytes
were transplanted to the oviducts of pseudopregnant foster mice. Three
stable male founders were generated (transgenic lines A–C) and back-
crossed with C57BL/6N wild-type female mice. All experiments were
performed on the sixth to 12th generation, male and female hemizygous
offspring of transgenicmouse line A. This transgenic reportermouse line
will be available for distribution from The Jackson Laboratory as stock
#025400.
Acute tissue isolation and dissociation, nuclear
microinjections
Male or female adult mice (30 d old) were anesthetized by CO2 inha-
lation and killed by decapitation before dissection. Various ganglia were
isolated and placed in chilled Hanks balanced salt solution for further
examination. For experiments requiring dissociated neurons, ganglia
were transferred to a dissociation medium consisting of 1.3 mg/ml col-
lagenase (CLS4; Worthington Biochemical), 0.2 mg/ml trypsin (Wor-
thington Biochemical), and 0.1 mg/ml DNase I in Earles’ balanced salt
solution supplemented with 3.6 g/L D-glucose and 10 mM HEPES. Gan-
glia were incubated at 36°C for 1 h in a water bath shaker rotating at 110
rpm. After incubation, neurons were mechanically dissociated by vigor-
ously shaking the flask for 10 s. Neurons were centrifuged (50 g for 6
min) and resuspended in minimum essential medium supplemented
with 10% FBS and 1% antibiotics (MEM/) twice before plating on
polyethylenimine-coated tissue culture dishes. Cells were maintained in
a humidified 95% air/5% CO2 incubator at 37°C.
Brains or spinal cord tissue were isolated and placed in chilled, oxy-
genated aCSF before slicing 300m sections with a vibratingmicrotome
(Leica). Slices were allowed to recover in oxygenated aCSF incubated at
32°C for 1 h. For hypothalamic neuron dissociation, younger mice (P19-
P23) and isoflurane were used. Coronal sections, 300m, were prepared
as described above before incubating slices in oxygenated aCSF contain-
ing 0.4 mg/ml Pronase (Calbiochem) at 36°C for 1 h. The hypothalamus
was trimmedwith a surgical blade andplaced in aCSF supplementedwith
soybean trypsin inhibitor and BSA (both 1 mg/ml). Tissue was mechan-
ically dissociatedwith a series of fire-polished Pasteur pipettes of decreas-
ing diameter before plating on polyethylenimine-coated tissue culture
dishes. Cells were allowed to settle for 30min at room temperature before
electrophysiological recording.
Plasmid cDNA (100 ng/l) similar to the construct used to generate
the transgenic mice (i.e., a 3.7 kb promoter region of Scn10a upstream of
the EGFP gene) was injected into the nuclei of DRG or nodose neurons
from adult (6- to 12-week-old) male Wistar rats, as previously described
(Ikeda, 2004; Lu et al., 2009). Briefly, 4–6 h following cell dissociation,
cDNA was injected with a FemtoJet microinjector and 5171 microma-
nipulator (Eppendorf) using an injection pressure and duration of 140–
160 hPa and 0.3 s, respectively. To identify successfully injected cells, a
mixture of nuclear-targeted dsRed2 constructs (dsRed2nuc, 5 ng/l
each; Clontech) under the control of one of following promoters: cyto-
megalovirus, ubiquitin, or elongation factor-1, was coinjected with the
reporter construct. Following injections, neurons were maintained in a
humidified 95% air/5% CO2 incubator at 37°C for 2 d in MEM
/
supplemented with 5 ng/ml nerve growth factor (NGF) and 5 ng/ml glial
cell line-derived neurotrophic factor (GDNF; Calbiochem).
Molecular biology
Primers and PCR amplification. The following primer sets were used for
PCR experiments. For genotyping: forward, 5-CTTCGTGGAGGAGC-
CCCGGAC-3, reverse, 5-GCTGAAGCACTGCACGCCGTAGG-3;
Scn10a: forward, 5-GGACCTGGCTCCATACCTGG-3, reverse, 5-
GAGGTTCACACCCATGATGCTG-3; -actin: forward, 5-GCCATC-
CTGCGTCTGGACCTG-3, reverse, 5-GTACTTGCGCTCAGGA
GGAGC-3.
Unless otherwise stated, PCR amplification was performed with 2
GoTaq Hot Start Polymerase Green Master Mix (Promega) for 35 cycles
(94°C for 30 s, 60°C for 30 s, and 72°C for 1 min) and final extension at
72°C for 5 min. PCR products were analyzed by agarose gel electropho-
resis and visualized using SYBR safe DNA gel stain (Invitrogen).
Genotyping. Ear punches were collected from anesthetized animals
and processed with the DNeasy Blood and Tissue kit (QIAGEN) follow-
ing the manufacturer’s instructions. The primer set used for genotyping
was designed to amplify the 3-end of the inserted Scn10a promoter
region and initial portion of the EGFP gene.
Single-cell PCR. Single DRG neurons, of small to medium diameter,
were collected by suction into a fire-polished glass capillary. The pipette
tip containing a single cell was broken inside a PCR tube containing
components from the OneStep RT-PCR kit (QIAGEN). First-strand
cDNA synthesis was performed at 50°C for 30 min. The samples were
then heated at 95°C for 15 min to inactivate reverse transcriptase and
activate HotStarTaq DNA polymerase. PCR was performed for 40 cycles
consisting of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min 30 s. The
final extension was performed at 72°C for 5 min. Scn10a transcript and
-actin mRNA, as an internal reference, were amplified concurrently
(i.e., multiplexed) with the primer sets detailed above.
cDNA synthesis and conventional PCR.Tissue punches of various brain
regions and whole ganglia were collected and placed immediately in cold
Trizol (Ambion). Samples were homogenized, total RNA was extracted
using the RNeasy micro kit (QIAGEN), and first strand cDNA was syn-
thesized withQuantiTect Reverse Transcription kit (QIAGEN) from 200
ng total RNA. PCR amplification of Scn10a (0.8M primers) and-actin
(0.2M primers) was performed concurrently. Primers were designed to
span intron sequences, thus eliminating interference from potential
genomic DNA contamination. In addition, a control reaction fromDRG
mRNA performed in the absence of reverse transcriptase was included.
qPCR.Quantitative real-time PCRwas performed with a StepOnePlus
Real-Time System, TaqManUniversal MasterMix II, and TaqMan Gene
Expression Assays (all from Applied Biosystems). Predesigned primer-
probe sets for mouse Scn10a (Mm00501467_m1) or -actin (mouse
ACTB, catalog #4352341E) and 1 l template cDNA from various brain
regions or whole ganglia were used in 20 l of reaction mixture. The
mixture was initially heated to 50°C for 5min, and 95°C for 10min, then
cycled 45 times through a melting step at 95°C for 15 s and annealing/
extension step at 60°C for 1 min. At least three biological replicates for
each tissue groupwere examined. To analyze the relative gene expression,
the comparative 2		Ctmethodwas used (Schmittgen and Livak, 2008).
Briefly, the CT values, defined as the cycle number at which the fluores-
cence intensity of the reporter dye crosses a threshold determined by
StepOne software, were obtained for Scn10a and -actin genes. The	CT
8022 • J. Neurosci., May 20, 2015 • 35(20):8021–8034 Lu et al. • Scn10a-EGFP Reporter Mouse Line
value for each sample was calculated using the equation: 	CT  CT
(Scn10a)CT (-actin). The fold difference in gene expression between
tissue groups was obtained from the formula 2		Ct  [	CT (tissue
group)mean 	CT for DRGs].
Immunostaining and imaging
Immunohistochemistry (IHC). Isolated tissues or hemisected brains were
drop-fixed in 4% PFA overnight at 4°C and then transferred to a 30%
sucrose solution at 4°C until tissues sank to the bottom of the vessel.
Tissues were immersed in Optimum Cutting Temperature Medium
(Tissue-Tek) and frozen at80°C. Thin (16–25 m) sections of tissue,
obtained using a cryostat (Leica), were mounted on SuperFrost Plus
microscope slides (Electron Microscopy Sciences) and stored at 20°C
before processing. Unless otherwise stated, the remaining IHC steps were
performed at room temperature. Cryosections were rehydrated in PBS
for 20 min, permeabilized with 0.3% Triton X-100 for 25 min, and im-
mersed in 0.2% Sudan Black B for 1.5 h to reduce lipofuscin-like auto-
fluorescence. Slides were destained with PBS for 1 h before blocking with
a solution of 4% nonfat milk, 2% BSA, and 2% normal goat serum in
Tris-buffered saline with 0.05% Tween 20 (TBS-T, 10 mM Tris base, 250
mMNaCl, pH 7.5) for 1 h. An extra blocking step with unconjugated goat
anti-mouse Fab fragments (10 g/ml, Jackson ImmunoResearch Labo-
ratories) in blocking solution was performed for 1 h before primary
antibody, chicken anti-EGFP (1:2000, Aves Labs, catalog #GFP-1010),
and mouse anti-Nav1.8 (1:10 tissue culture supernatant, NeuroMab,
clone N134/12) was applied overnight at 4°C. According to the product
datasheet, the Nav1.8 antibody used in these experiments was developed
against the C terminus of ratNav1.8 (amino acids 1724–1956), which has
93% identity with mouse Nav1.8, has reactivity in mouse tissue, and has
been validated in a Nav1.8 knock-out mouse. Secondary antibodies, goat
anti-chicken conjugated to AlexaFluor-488 and goat anti-mouse conju-
gated to AlexaFluor-555 (both 1:2000, Invitrogen) were applied for 2 h.
After sufficient washing with TBS-T and PBS, coverslips were mounted
on slides with Fluoromount-G (Electron Microscopy Sciences).
Hematoxylin and eosin staining of skin sections. Skin from the mouse
footpad was removed, fixed with 4% PFA for 30 s, and flash frozen in
liquid nitrogen. Thin cryosections were mounted on SuperFrost Plus
microscope slides, completely dried, then rehydrated with PBS, and a
coverslip was mounted with Fluoromount-G (Electron Microscopy Sci-
ences). Fluorescence images were acquired before counterstaining with
the NovaUltra H and E stain kit (IHCWorld), as per the manufacturer’s
instructions.
Live-cell staining. Two hours after plating, dissociated neurons on tis-
sue culture dishes were removed from the incubator and gently washed
with Dulbecco’s PBS with Ca2 andMg2 (DPBS/), then exchanged
with a blocking solution of 2% BSA in DPBS/ with 0.03% Triton
X-100. Isolectin B4 (IB4) conjugated to AlexaFluor-568 (5 g/ml, Invit-
rogen) or cholera toxin B subunit (CtB) conjugated to rhodamine (5
g/ml, List Biological) was added and dishes were incubated at 37°C for
30 min. Neurons were washed 3 with blocking solution then 3 with
DPBS/. Dishes were kept in the dark until image acquisition.
Immunocytochemistry (ICC).Dissociated neurons plated on tissue cul-
ture disheswere gentlywashedwith PBS before fixingwith 2%PFA for 30
min at room temperature. After washing out fixative with PBS, neurons
were permeabilized with 0.3% Triton X-100 in PBS for 20 min at room
temperature. Following solution exchange with PBS, a blocking solution
of 4% nonfat milk, 2% BSA, and 2% normal goat serum in TBS-T was
added for 1 h at room temperature. For dishes treatedwithmousemono-
clonal primary antibodies, an additional incubation with unconjugated
goat anti-mouse Fab fragments (10 g/ml) in blocking solution was
applied for 1 h at room temperature after the blocking step. Primary
antibodies in blocking solution were incubated with cells overnight at
4°C. One of the following primary antibodies was applied: mouse anti-
Nav1.7 (1:400, NeuroMab, clone 68/6), mouse anti-Nav1.8 (1:200 puri-
fied antibody or 1:10 tissue culture supernatant, NeuroMab, clone 134/
12), mouse anti-EGFP (1:400, Millipore Bioscience Research Reagents,
catalog #MAB3580), rabbit anti-Neurofilament 200 (1:2000, Abcam, cat-
alog #ab8135), mouse anti-calcitonin gene-related peptide (CGRP;
1:300, Abcam, catalog #ab81887), rabbit anti-Substance P (1:1000, Im-
munoStar, catalog #20064), and rabbit anti-TH (1:1000, Pel-Freez,
P40101). After washing cells with TBS-T for 1 h, cells were treated with
fluorescently tagged secondary antibodies (goat anti-mouse or goat anti-
rabbit conjugated to AlexaFluor-555, 1:2000, Invitrogen) for 2 h at room
temperature. Cells were washed with TBS-T for 1 h and then exchanged
for PBS before imaging. All staining experiments included parallel nega-
tive controls, which received the same treatment except without primary
antibody incubation.
Fluorescence imaging. Thick tissues (100 m) were imaged with a
Zeiss LSM510 Meta confocal microscope using ZEN 2008 acquisition
software (Carl Zeiss). z-stack images were acquired with a 488 nm exci-
tation wavelength and a 500–550 nm bandpass emission filter using a
10 objective (0.30 NA), and then compiled to a single Z-projection
image. For lower-magnification fluorescence images, an Olympus
MVX10 microscope was used. To image IHC and ICC experiments,
phase-contrast and fluorescence images were acquired using a Zeiss Ob-
server Z1microscope (Carl Zeiss) equipped for fluorescence imaging and
an Andor CCD camera (Clara) controlled by open-source Microman-
ager software (version 1.4.18) (Edelstein et al., 2010) or a Zeiss Axiovert
200 microscope (Carl Zeiss) equipped for fluorescence imaging and a
Hamamatsu CCD camera (ORCA-ER) controlled by Volocity acquisi-
tion software. Either a 20 (0.40 NA) or 63 (1.2 NA) objective was
used. Filters appropriate for EGFP (472/30 nm excitation, 520/35 nm
emission), and red fluorescence (534/22 nm excitation, 593/40 nm emis-
sion) were used and exposure times for green (2 s) and red (0.5 s) fluo-
rescence images were kept consistent across all samples.
Electrophysiology
Na-channel currents (INa) were recorded using conventional whole-
cell patch-clamp techniques (Hamill et al., 1981). Patch electrodes were
pulled from borosilicate glass capillaries (1.65 mm outer diameter, 1.20
mm inner diameter, King Precision Glass) using a Model P-97 micropi-
pette puller (Sutter Instrument). The patch electrodes were coated with
silicone elastomer (Sylgard 184, Dow Corning) and fire-polished. A Ag/
AgCl pellet connected to the bath solution via a 0.15MNaCl/agar bridge
was used as a ground. The cell membrane capacitance was cancelled, and
series resistance was compensated (85% prediction and correction; lag
set to 5 s) with a patch-clamp amplifier (Axopatch 200B, Molecular
Devices). Voltage protocol generation and data acquisition were per-
formed using custom-designed software (S5) on a Macintosh G4 com-
puter (Apple). Current traces were filtered at 5 kHz (3 dB; 4-pole
Bessel), digitized at 10 kHz with a 16-bit analog-to-digital converter
board (ITC-18, HEKA), and stored on the computer for later analyses.
For recording INa from DRG neurons, patch pipettes were filled with
an internal solution containing the following (in mM): 30 NaCl, 80 Cs
methanesulfonate, 10 HEPES, 10 sucrose, 11 EGTA, 1 CaCl2, 6 Tris-
creatine phosphate, 4 Mg-ATP, 0.1 Na2-GTP, pH 7.2, with TEA-OH.
External INa recording solution consisted of the following (in mM): 60
NaCl, 60 TEA-Cl, 10 HEPES, 15 D-glucose, 10 MgCl2, osmolality ad-
justed to 310–320 mOsm with sucrose, pH 7.4, with TEA-OH. For re-
cording INa from central neurons, NaCl was reduced in the internal
solution to 10 and 100 mM CsF replaced Cs methanesulfonate. Also, the
concentration of NaCl was increased to 140 mM in the external INa re-
cording solution. All recordings were performed at room temperature
(20°C–24°C).
Drugs for electrophysiological experiments were diluted to final con-
centrations from stock solutions on the day of experiment and applied
directly onto neurons using a custom-made gravity-fed perfusion system
with separate perfusion lines feeding into a 4-bore glass capillary tube
(VitroCom) connected to a fused silica capillary tube. A constant flow of
external solution was applied onto cells during baseline recordings and
switched to a drug solution during drug applications to avoid flow-
induced artifacts. Tetrodotoxin-resistant (TTX-R) INawasmeasured fol-
lowing application of 3 M TTX and TTX-sensitive (TTX-S) INa was
obtained by subtracting TTX-R INa traces from total INa (INa traces re-
corded before TTX application).
INa-voltage relationships were studied by applying a series of 70 ms
depolarizing voltage steps from a holding potential of 80 mV, every
10 s. To generate activation curves, peak inward currents from the I–V
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recording protocol were converted to conduc-
tance values using the equation, G  I/(Vm 
ENa), where G is conductance, I is the peak
current, Vm is the membrane potential step
used to elicit the response, and ENa is the rever-
sal potential for sodium (determined from the
x-axis intercept of a linear fit to the ascending
limb of the I–V curve). Conductance was nor-
malized to the maximum conductance value
and fit (Marquardt-Levenberg algorithm, Igor
PRO version 6.3, WaveMetrics) to the Boltz-
mann equation G/Gmax  1/(1  exp[(Vm 
V1/2,act)/ka]), where G/Gmax is the fractional
peak membrane conductance, Vm is the mem-
brane potential, V1/2,act is the half-activation
voltage, and ka is a slope factor. To generate
steady-state inactivation curves, cells were
stepped with a series of 500 ms conditioning
pulses (100 to50mV) followedby a100ms test
pulse to 10 mV. Peak inward currents from the
test pulse were normalized to themaximum cur-
rent amplitude and fit to theBoltzmannequation
I/Imax 1/(1 exp[(VcV1/2,inact)/ki]), where I
is thepeak INa evokedduring the testpulse, Imax is
themaximal current,Vc is the voltage of the con-
ditioning pulse before the test pulse, V1/2,inact is
the half-inactivation voltage, and ki is a slope
factor.
Drugs and chemicals, analysis and
statistical testing
Unless otherwise stated, all chemicals were pur-
chased from Sigma-Aldrich. A-803467 was pur-
chased from Alomone Labs, and TTX was
purchased fromAbcam.
ImageJ software (version 1.48) was used to
analyze and adjust contrast of images for pre-
sentation in figures. IGOR Pro software (ver-
sion 6.3, WaveMetrics) was used to analyze
current traces and ICC experiments. For an-
alyzing colabeling experiments, a custom-
written program in IGOR Pro was used to
automatically select regions of interest around
neurons in phase-contrast images, and fluores-
cence intensity wasmeasured from subsequent
images from the green and red fluorescence
channels.
Statistical tests were performed with Graph-
Pad Prism 6 for Mac OS X (GraphPad Soft-
ware). Data are expressed as mean 
 SEM,
except for Figure 6Eiiwhere the proportions of
cells with 95% confidence intervals are shown.
Statistical significance between two groups was
determined using an unpaired Student’s t test
or the Fisher’s exact test for Figure 6Eii, and
an ANOVA with Holm-Sidak’s multiple-
comparisons test was used to statistically com-
pare three or more groups. p  0.05 was
considered statistically significant.
Results
Generation of transgenic mouse lines
Three transgenic mouse lines were gener-
ated following pronuclear injection of the
putative Scn10a promoter construct (Fig.
1A). Offspring from founder mice B failed to breed and this line
could not be maintained. Transgenic mouse line C continued to
breed but EGFP expression in peripheral sensory ganglia steadily
declined in subsequent generations. By the fourth generation, the
percentage of DRG neurons expressing EGFP dropped to10%;
therefore, transgenic line C was not studied further. EGFP ex-
pression in the DRG of transgenic mouse line A was relatively
Figure1. EGFPexpression in peripheral sensory neurons andprimary sensory afferent fibers of Scn10a-EGFPmice.A, Schematic
of linearized construct used to generate transgenic mouse line. A 3.7 kb sequence upstream of a 24 kb intron and transcriptional
start site (TSS) of the Scn10agenewas used as the promoter to drive EGFP expression in transgenicmice.B–D, Top, Phase-contrast
images. Bottom, EGFP fluorescence images. B, Thoracic DRG. C, Dorsal root branch. D, Dorsal side of a transverse spinal cord slice
(300m). Note the EGFP fibers terminating in Lamina II of the spinal cord. E, Cross-section ofmouse footpad (glabrous) skin. Top,
Hematoxylin and eosin stain of glabrous skin section clearly labeling the stratum corneum (sc), epidermis (ep), and dermis (d) layers.
Bottom, Fluorescence image of skin section taken before hematoxylin and eosin staining. Note the EGFP fibers extending into dermal
papillae and terminating in the dermis layer, not crossing into the stratum spinosum layer of the epidermis. Scale bars, 100m.
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high in a large number of cells (Fig. 1B) and consistent up to the
12th generation offspring. Insertion of the transgene randomly
into the genome appeared to be well tolerated in transgenic
mouse line A as no overt abnormalities in development or breed-
ing were observed. All further experiments in this study used
transgenic line A.
EGFP expression in DRG neurons and primary sensory
afferents terminals
As mentioned previously, EGFP was observed within cell bodies
of the DRG (Fig. 1B) and fibers in the dorsal root branch (Fig.
1C). Neurons expressing EGFP were distributed throughout the
ganglion, and EGFP expression was similar in all DRG along the
spinal column (data not shown). In enzymatically dissociated
DRG neurons of Scn10a-EGFP mice, the percentage of neurons
expressing EGFP ranged between 20% and 71% and averaged
46% (Table 1; n 40). Sporadically, a mouse genotyped as pos-
itive for the transgene would have little to no EGFP in DRG
neurons (5 of 95 positive mice with 2% total DRG neurons
expressing EGFP). No age- or sex-related association between
affected animals could be determined. Tissue samples from these
animals were excluded from analysis, and only Scn10a-EGFP-
positivemice with20%ofDRGneurons expressing EGFPwere
characterized further.
Primary sensory afferents project to the dorsal horn of the
spinal cord, and EGFP was observed in acutely prepared spinal
cord slices from Scn10a-EGFP-positivemice (Fig. 1D). The EGFP
signal concentrated in the substantia gelatinosa or Lamina II of
the dorsal horn where C-fibers predominantly terminate. Pri-
mary sensory afferents also project to peripheral tissues, includ-
ing the skin, and EGFP expression was probed in skin samples
from the footpads of Scn10a-EGFP-positive mice (Fig. 1E).
Bright EGFP-positive fibers were detected in the dermis layer of
footpad skin extending into dermal papillae but do not cross into
the stratum spinosum layer of the epidermis. Hence, primary
sensory neuron somata, fibers, and both central and peripheral
terminals from Scn10a-EGFP mice express EGFP.
EGFP expression in DRG neurons correlates with Scn10a
mRNA and Nav1.8 protein
To validate the Scn10a-EGFP mouse line as an effective reporter
of voltage-gated sodium channels subtype 1.8 (Nav1.8), the cor-
relation between EGFP expression and Scn10a gene products was
assessed.
Individual DRG neurons from Scn10a-EGFP mice were se-
lected following enzymatic dissociation and subjected to single-
cell PCR. Scn10a and -actin transcripts were amplified, and the
PCR products obtained are shown in Figure 2B. A 742 bp ampli-
con, corresponding to the predicted size of Scn10a transcript, was
detected in 35 of 37 EGFP-positive DRG neurons. Therefore,
EGFP expression in Scn10a-EGFP mice correlates well with the
presence of Scn10amRNA.
An antibody with reactivity to mouse Nav1.8 was used to detect
thepresenceofNav1.8protein.WholeDRGsections anddissociated
DRGs from Scn10a-EGFP mice were subject to immunostaining
and fluorescence imaging (Fig. 3A). Most small- to medium-
diameter DRG neurons expressed EGFP (Fig. 3A, middle panels;
mean diameter 26.5
 0.02m, n 43,608 EGFP-positive DRG
neurons from 40 animals) and were immunoreactive to Nav1.8
(Nav1.8-IR; Fig. 3A, right panels). An x-y plot of the fluorescence
intensity in the red and green channels from individual DRG
neurons reveals four discrete populations (Fig. 3B). Themajority
of cells are within the top right and bottom left quadrants of the
scatterplot corresponding to the EGFP-positive/Nav1.8-IR and
EGFP-negative/non-Nav1.8-IR population, respectively; 80% of
all Nav1.8-IR cells expressed EGFP, and almost 70% of all EGFP-
positive DRGneurons were immunoreactive toNav1.8 (Table 1).
As a control, an antibody against EGFP was used to test ICC and
analysis procedures. Almost 98%of EGFP-positiveDRGneurons
were immunoreactive to the EGFP antibody (Table 1).
Currents from Nav1.8 channels have distinct biophysical
properties and can be pharmacologically isolated using TTX.
Therefore, using solutions designed to isolate sodium currents
Table 1. Characterization of the EGFP-positive peripheral sensory neuron
populationa
Label % positive for label
% double-labeled cells
(as % EGFP-positive
cells)
% double-labeled cells
(as % label-positive
cells)
For DRG neurons
EGFP, transgene
expression
45.7
 2.2 (40)
EGFP-IR 35.5
 3.6 (4) 97.9
 1.2 90.7
 2.8
Nav1.8 44.6
 2.2 (12) 69.7
 1.6 80.2
 4.6
IB4 35.4
 1.5 (18) 56.7
 1.7 75.2
 4.2
CGRP 14.6
 1.1 (5) 18.7
 0.9 61.4
 4.0
Substance P 8.0
 0.8 (4) 7.2
 0.9 45.9
 4.7
CtB 36.5
 1.3 (12) 9.6
 1.0 11.4
 1.7
NF200 25.9
 1.1 (3) 8.6
 1.4 10.8
 3.3
TH 9.0
 0.7 (5) 5.6
 0.3 32.2
 3.9
Nav1.7 91.3
 3.0 (9) 95.8
 1.7 41.9
 5.0
For ND neurons
EGFP, transgene
expression
7.0
 1.2 (13)
Nav1.8 46.1
 9.0 (5) 82.9
 10.2 14.6
 3.8
aSummary of live-cell staining and ICC experiments on dissociated DRG or ND neurons isolated from Scn10a-EGFP
mice. Fluorescence from individual neuronsmeasured using a customprogramwrittenwith Igor software (detailed
inMaterials andMethods). Stainingwith secondary antibodyalone (i.e. noprimaryantibody)wasused todetermine
the boundary between positive and negative red fluorescence intensity, and the boundary between positive and
negative green fluorescencewas set at 750 (for the two discrete populations of EGFP fluorescence intensity, see Fig.
3B). Double-labeled (EGFP-positive and label-positive) neurons expressed as either a percentage of total EGFP-
positive (middle column) or label-positive (right column) neurons. n values for each group are biological replicates
(different animals) and indicated in parentheses.
Figure 2. Correlation of EGFP expression with Scn10a transcript in DRG neurons from
Scn10a-EGFP mice. A, Schematic of primer set used to amplify Scn10a transcript by single-cell
PCR. Primers were designed to span 6 exons (exon 18–23) and generate a 742 bp amplicon.B,
The resultant PCR products were separated and visualized on a 1.5% agarose gel. -actin
amplicon is 500 bp in length.
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(INa) and whole-cell voltage-clamp electrophysiology, Nav1.8
protein function in EGFP-expressingDRGneurons was assessed.
Both TTX-S and TTX-R INa were recorded from DRG neurons
using a series of commandpulses fromaholding potential of80
mV (Fig. 4A). TTX-R INa, or INa, recorded in the presence of 3M
TTX, reached its peak in10 ms and slowly decayed to a steady-
state within 60 ms. TTX-S currents, derived from subtracting
TTX-R INa from INa recorded before application of TTX, rose to a
peak within 2 ms and decayed to baseline within 20 ms. The
proportion of TTX-R INa relative to total INa was calculated for
EGFP and non–EGFP-expressing DRG neurons (Fig. 4B); and in
every EGFP-expressing cell recorded, TTX-R INa was detected
(n 34). The I–V relationship of peak TTX-S (gray circles) and
TTX-R (white-filled circles) INa is shown in Figure 4C.Maximum
TTX-S INa amplitude was reached at5mV, whereas TTX-R INa
amplitude reached amaximum10mVmore depolarized at 5mV.
Both components of INa reversed near 30mV. The voltage depen-
dence of activation was determined by transforming the peak INa
versus voltage curves into conductance versus voltage (G–V)
curves as described inMaterials andMethods. The averages of the
normalizedG–V curves (G/Gmax) for TTX-R and TTX-S compo-
nents are shown in Figure 4D. The G–V curve was fit to a Boltz-
mann function that provides the voltagemidpoint as well as slope
factor of the voltage-dependent response as parameters (Table 2).
The activation voltage range for TTX-S channels was30 mV to
5 mV, with a half-maximal conductance at 21 mV. For
Figure 3. Correlation of EGFP expression with Nav1.8 protein in DRG neurons from Scn10a-EGFP mice. A, Immunoreactivity (IR) of DRGs from an Scn10a-EGFP mouse to antibodies
against Nav1.8 protein (NeuroMab). Phase-contrast (left), EGFP (middle), and red fluorescence (right) images of immunostained DRGs. Top, IHC of sectioned DRG tissue. Bottom, ICC of
dissociated DRG neurons. White arrowheads indicate EGFP-positive DRG neurons lacking Nav1.8-IR. Yellow arrowheads indicate Nav1.8-IR DRG neurons lacking EGFP expression. Scale
bar, 50 m. B, Scatterplot from a representative ICC experiment. Green and red fluorescence intensity represents transgene (EGFP) expression and Nav1.8-IR, respectively, of DRG
neurons from Scn10a-EGFP mice. ROIs were automatically selected around dissociated DRG neurons in the phase-contrast image, and fluorescence intensity was measured from
subsequent images collected from green and red channels. Each dot indicates an individual cell. Dashed lines indicate the boundary between groups determined by staining in negative
controls (secondary antibody alone) and visual confirmation.
Figure 4. Correlation of EGFP expression with functional Nav1.8 channels in DRG neurons from Scn10a-EGFP mice. A, Representative electrophysiological recording traces of sodium
currents (INa) from an EGFP-negative (i) or EGFP-positive DRG neuron in the presence of 3M TTX (ii). Note the slower activation and inactivation kinetics of TTX-R INa. Calibration: y-axis,
1 nA; x-axis, 5 ms for both. B, Proportion of TTX-R INa, expressed as a percentage of total INa, in EGFP-positive () and EGFP-negative (f) DRG neurons. Peak INa amplitude recorded at
0 mV before and after application of 3M TTX was used to calculate percentages. Each symbol represents an individual cell. N values for each group are indicated on graph in parentheses.
TTX-R INawas detected in all EGFP-positive DRG neurons recorded (34 of 34). C, INa–voltage relationship curves for TTX-S ( ) and TTX-R (E) INa recorded from EGFP-positive DRG neurons.
Traces of INa recorded in the presence of TTX were subtracted from traces of total INa, recorded before application of TTX, at the same voltages to reveal the TTX-S component of INa. Peak
INa amplitude was plotted against the voltage step used to elicit currents and normalized to maximum peak INa recorded. D, Voltage dependence of activation and inactivation
(h-curves) for TTX-S ( ) and TTX-R (E) INa. All voltage protocols and equations used to calculate the voltage of half-activation (V1/2,act) or half-inactivation (V1/2,inact) and slope factor
(k) values are detailed in Materials and Methods.
Table 2. Biophysical properties of TTX-S and TTX-R INa components of EGFP-positive
DRG neuronsa
TTX-S INa TTX-R INa
V1/2,act (mV) 20.6
 0.3 6.7
 0.2*
ka (mV) 4.0
 0.2 3.7
 0.2
V1/2,inact (mV) 60.7
 1.1 25.3
 0.6*
ki (mV) 8.9
 0.9 6.9
 0.6
aSummary of sodium channel properties of EGFP-positive DRG neurons from Scn10a-EGFP mice. TTX-R INa were
recorded in the presence of 3M TTX, and TTX-S INawere derived from subtracting the TTX-R component of INa from
total INa, recorded before application of TTX. All voltage protocols and equations used to calculate V1/2 and k values
are detailed in Materials and Methods. Complete activation curves were constructed from recordings of 28 EGFP-
positive DRG neurons, and the inactivation protocol was successfully applied to 23 EGFP-positive DRG neurons. Data
are mean
 SEM.
*p 0.001 (Student’s t test).
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TTX-R channels, the activation voltage range was 25 mV to 5
mV, with a half-maximal conductance at6.7 mV. The voltage
dependence of steady-state inactivation, or h, curve, was plotted
as normalized peak INa from the test pulse following inactivation
pulses versus the voltage of the inactivating conditioning pulse
(Fig. 4D) and fit to a Boltzmann function to calculate the voltage
midpoint of inactivation and slope factor (Table 2). TheV1/2,inact,
or voltage of half-inactivation, for TTX-R channels is signifi-
cantly shifted in the depolarizing direction comparedwithTTX-S
channels (Fig. 4D; Table 2; p 0.001, Student’s t test). Thus, the
properties of TTX-R INa recorded from EGFP-positive DRG
neurons were similar to TTX-R INa recorded previously from
DRG neurons and heterologously expressed Nav1.8 channels
in sympathetic neurons (Akopian et al., 1999; Fjell et al.,
1999a, 1999b; Schofield et al., 2008; Han et al., 2014). Overall,
EGFP expression in Scn10a-EGFP mice correlates well with
the presence of Nav1.8.
Characterization of EGFP-expressing DRG neurons from
Scn10a-EGFP mice
Because growth factors can influence the expression of Nav1.8
(Dib-Hajj et al., 1998; Fjell et al., 1999a, b; Leffler and Cummins,
2002), expression of the EGFP transgene in the presence of
growth factors was tested (Fig. 5A). The EGFP signal in DRG
neurons from Scn10a-EGFPmice disappeared after 6 d in culture
with normal medium. However, EGFP expression was detected
after 6 d in culture with medium supplemented with GDNF or
NGF. Therefore, the inserted transgene displays growth factor
dependence similar to Nav1.8 channels.
To further characterize the population of DRG neurons la-
beled by the reporter transgene, dissociated DRG neurons from
Scn10a-EGFP mice were colabeled with various markers of
distinct DRG populations. IB4, from Griffonia simplicifolia, rec-
ognizes terminal -D-galactosyl residues and identifies nonpep-
tidergic unmyelinated primary afferent neurons (Stucky and
Lewin, 1999). Live-cell imaging of acutely dissociated DRG neu-
rons from an Scn10a-EGFP-positivemouse treated with IB4 con-
jugated to fluorescent dye is shown in Figure 5B. IB4 binding was
detected in 35% of all DRG neurons and 50% of EGFP-
expressing DRG neurons of transgenic mice (Table 1). Indeed,
75% of IB4-positive DRG neurons in transgenic mice also ex-
pressed EGFP. A histogram of the number of cells versus cell
diameter is shown in Figure 5C. EGFP-expressing DRG neurons
displayed a multimodal distribution (white bars) ranging in
diameter from 11 to 48 m with three distinct populations dis-
tributed around diameters of 20, 25, and 35 m. IB4 binding
EGFP-positive DRG neurons accounts for nearly all of the DRG
neurons within the small- to medium-sized population (filled
purple bars). The peptidergic population of DRG neurons ex-
pressing CGRP or Substance P was also probed in EGFP-positive
DRG neurons. Although a small percentage of DRG neurons
were immunoreactive positive (IR-positive) for CGRP and Sub-
stance P (15% and 8%, respectively), a large proportion of both
peptidergic populations expressed the EGFP transgene (Table 1).
Over 60% of CGRP-IR-positive and 46% of Substance P-IR-
positive DRG neurons expressed EGFP in transgenic mice. The
proportion of A-fiber neurons in transgenic mice expressing
EGFP was probed using fluorescently tagged CtB and antibodies
against Neurofilament 200 (NF200). Approximately 9% of
EGFP-positive neurons colabeled with markers of A-fibers and
10% of DRG neurons positive for CtB binding or NF200-IR also
expressed EGFP (Table 1). So, a small population of A-fiber neu-
rons in Scn10a-EGFPmice expressed the EGFP transgene. A sub-
population of DRG neurons containing TH was examined as
well. TH-IR was found in 5.6% of EGFP-positive neurons, and
30% of TH-IR-positive neurons expressed EGFP (Table 1).
Last, almost all EGFP-expressing DRG neurons in Scn10a-EGFP
mice coexpressed the voltage-gated sodium channel subtype 1.7
(Nav1.7; Table 1), a TTX-S channel commonly expressed in no-
ciceptive DRG neurons.
Lack of EGFP expression in placodal-derived sensory ganglia
of Scn10a-EGFP mice
TTX-R INa, with properties similar to the currents observed in
this study, has been reported in cranial sensory ganglia (Ikeda et
al., 1986; Cummins et al., 2002; Nakamura and Bradley, 2011).
Because most of the TTX-R INa in these studies was attributed to
Nav1.8 channels, we expected EGFP expression in sensory neu-
rons derived from cranial ganglia of transgenic mice similar to
DRGs. However, there was a lack of EGFP expression in several
cranial ganglia of Scn10a-EGFP mice. In the nodose ganglion,
sparse EGFP-positive cell bodies were present at the rostral end of
the ganglion (Fig. 6Ai). Only 7% of nodose neurons in transgenic
mice expressed EGFP compared with 45% of DRG neurons
(Table 1). A recent study has demonstrated fusion of neurons
from the jugular ganglion into the rostral end of the nodose gan-
glion inmice (Nassenstein et al., 2010). Examination further ros-
tral to the nodose ganglion of transgenic mice revealed that the
jugular ganglion directly adjacent to the nodose ganglion had an
abundance of bright EGFP-positive cell bodies (Fig. 6Aii). There-
fore, nodose ganglia of Scn10a-EGFPmice lack transgene expres-
sion because the EGFP expression observed in the nodose
ganglionmay actually be EGFP-positive neurons from the jug-
ular ganglion. To confirm the presence of Nav1.8 protein in
the nodose ganglion of Scn10a-EGFP mice, immunostaining
experiments using an antibody against mouse Nav1.8 was
used. Thin sections of a nodose ganglion from a transgenic
mouse show positive staining for Nav1.8 (Fig. 6Aiii), and
45% of dissociated nodose ganglion neurons display Nav1.8-
IR, similar to the percentage obtained from dissociated DRG
neurons (Table 1).
The previously mentioned study (Nassenstein et al., 2010)
differentiated jugular and nodose neurons by crossing a
-galactosidase reporter mouse with the Wnt1-Cre mouse line,
which expresses Cre-recombinase in early migratory neural crest
cells. Because neural crest-derived neurons, such as those from
the DRG and jugular ganglia, of transgenic mice express EGFP
but not placodal-derived neurons from the nodose ganglion, we
examined cranial ganglia that originate from neurogenic pla-
codes to determine whether a correlation exists between expres-
sion of our transgene and the embryological origin of neurons.
Similar to the nodose ganglion, EGFP was absent in the petrosal
ganglion (Fig. 6B) and geniculate ganglion (Fig. 6C). Neurons
within the trigeminal ganglion have a mixed embryological ori-
gin; neurons in the distal portions of the trigeminal ganglion,
which develop from the trigeminal placode, appear to have di-
minished EGFP expression (Fig. 6D).
To confirm that the lack of EGFP expression in placodal-
derived sensory ganglia is not an artifact of transgenic mouse
generation (i.e., random insertion of the transgene into the ge-
nome), acute expression of the reporter construct used to develop
Scn10a-EGFP mice was tested in dissociated nodose ganglion
neurons. Injection of plasmid cDNA into the nucleus of neurons
has been successfully used in previous studies to heterologously
express proteins of interest (Ikeda, 2004) and to assay Scn10a
promoter activity (Puhl and Ikeda, 2008). Because of the fused
Lu et al. • Scn10a-EGFP Reporter Mouse Line J. Neurosci., May 20, 2015 • 35(20):8021–8034 • 8027
jugular-nodose ganglia complex in mice, rat nodose and DRG
neurons were injected with a plasmid construct consisting of
the putative Scn10a promoter and EGFP gene, along with
dsRed2nuc cDNA, to identify successfully injected neurons
(Fig. 6Ei). Almost 40% of injected rat DRG neurons expressed
EGFP, but 5% of injected rat nodose ganglion neurons ex-
pressed EGFP, which is statistically significant (Fig. 6Eii; p 
0.001, Fisher’s exact test). Similar percentages of EGFP-
positive neurons were observed from the dissociated ganglia of
transgenic animals. Thus, our inserted transgene construct
failed to report Scn10a expression in placodal-derived sensory
ganglia.
Figure 5. Characterization of EGFP-expressing DRG neurons from Scn10a-EGFP mice. A, Growth factor dependence of EGFP expression in DRG neurons from transgenic mice under untreated
control (left), GDNF (middle), or NGF (right) conditions after 6 d in culture (DIC). Top, Phase-contrast images. Bottom, EGFP fluorescence images. Scale bar, 50m. B, Phase-contrast (left), EGFP
(middle), and red fluorescence (right) images of IB4-AlexaFluor-568-stained DRG neurons from transgenicmice.White arrowhead indicates EGFP-positive DRG neurons not bound to IB4. Scale bar,
50 m. C, Distribution of EGFP-positive DRG neurons from Scn10a-EGFP mice (white bars). Purple-filled bars indicate EGFP-positive DRG neurons that were also IB4-positive. The IB4-positive
population accounts for a large proportion of small- to medium-sized EGFP-positive neurons.
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EGFP expression outside of the nervous system of
Scn10a-EGFP mice
The expression ofNav1.8 is highly restricted to peripheral sensory
ganglia neurons. However, recent reports suggest expression of
Nav1.8 outside of the nervous system. We therefore investigated
the presence of EGFP in these regions and tested for possible
ectopic EGFP expression.
EGFP-positive cells were observed within transverse sections
of cardiac tissues of Scn10a-EGFP mice (Fig. 7Ai). Positive cells
were found in fat pads at the base of the aorta and pulmonary
artery, in an area corresponding to the cardiac ganglion. Al-
though Nav1.8-IR is found in human cardiomyocytes (Facer et
al., 2011), we did not observe EGFP expression in the myocar-
dium of transgenic mice (Fig. 7Aii).
A recent study suggests the presence ofNav1.8 in human testes
(Cejudo-Roman et al., 2013) and retina (O’Brien et al., 2008);
however, we did not observe a EGFP signal or EGFP immunore-
activity (EGFP-IR) in the testes (Fig. 7B) or eyes (Fig. 7C) of
transgenic mice. Various tissues from Scn10a-EGFP mice were
also probed with an antibody against EGFP, and a weak positive
signal was observed in the pancreas (Fig. 7D) and kidney (Fig.
7E). No EGFP expression was detected in the spleen, liver, lung,
small and large intestine, or stomach of Scn10a-EGFPmice (data
not shown).
A bright EGFP signal was observed from the footpads of
EGFP-positive mice but not wild-type littermates (Fig. 7Fi).
EGFP expression was bright enough to observe under fluores-
cence microscopy without amplification by immunostaining
procedures. The majority of the EGFP signal emanated from the
superficial layers of the epidermis (Fig. 7Fiii), not the peripheral
afferent terminal fibers mentioned previously (Fig. 1E). It is un-
likely EGFP expression in the outer skin layers reflects functional
expression of Nav1.8 channels because the superficial epidermis
consists of dead, keratinized cells without a cytoplasmor nucleus.
EGFP expression in the outer skin layers may reflect ectopic trans-
gene activation as a result of epithelium differentiation, which in-
volvesamassiveupregulationof transcription factors (for review, see
Fuchs, 1990). Interestingly, one of these transcription factors may
regulate Scn10a expression. Moreover, this bright superficial EGFP
signal could prove to be a convenient alternative to genotyping for
the identification of transgenic positive mice.
An EGFP signal was also visible in the nose of genotype-
positive mice (Fig. 7G), which was most visible in young pups
(3 d old). The Grueneberg ganglion, an olfactory organ capable
of detecting alarm pheromones and cold temperatures (Ma-
masuew et al., 2008; Fleischer and Breer, 2010; Schmid et al.,
2010), is located within the nasal cavity, and dissection of this gan-
glion revealedEGFPexpression(Fig. 7G, right).TheabilityofNav1.8
channels to transmit electrical impulses at low temperatures (Zim-
mermann et al., 2007), which aligns with the cold-sensing function
of the Grueneberg ganglion, and the presence of TTX-R INa from
Grueneberg ganglion cells (Liu et al., 2012) supports the presence of
Nav1.8 expression in the Grueneberg ganglion.
EGFP expression in the CNS of Scn10a-EGFP mice
EGFP expression was examined in the brains of transgenic mice
as well (Fig. 8A). The basolateral amygdala contained a number
of EGFP-positive cells. Cells expressing EGFP were also found in
the brainstem, in a cluster of cells close to the spinal nucleus of the
trigeminal nerve and sparsely distributed cell bodies in the me-
dulla oblongata. Unlike Gautron et al. (2011), no EGFP signal
was observed in the nucleus of the solitary tract likely because of
the lack of EGFP transgene expression in the nodose ganglion
(Fig. 6A). EGFP-expressing cells were distributed throughout the
Figure 6. Lack of EGFP expression in placodal-derived ganglia from Scn10a-EGFP mice. A, Nodose ganglia. Ai, Phase-contrast (top) and EGFP fluorescence (bottom) images of the same nodose
ganglion. EGFP fluorescence was predominantly at the rostral end of the nodose ganglion. Arrow indicates the rostral (R)-caudal (C) orientation. Aii, Fluorescence image of the jugular-nodose
ganglion complex froman Scn10a-EGFPmouse. JG, Jugular ganglion.Aiii, Immunohistochemistry of a sectionednodoseganglion. Lower-magnification images are on the left; higher-magnification
images are on the right. There is no EGFP fluorescence in the nodose section (top) but an abundance of Nav1.8-IR (bottom). B–D, Top, Bright-field images. Bottom, EGFP fluorescence images. B,
Petrosal ganglion, indicated by blue arrow. C, Geniculate ganglion, indicated by blue arrow. D, Trigeminal ganglion, distal portion indicated by blue arrow. E, Summary of nuclear injection
experimentswith primary rat neurons andplasmid construct consisting of the putative Scn10apromoter and EGFPgene.Ei, Sample images of positive (above) or negative (below) neuron for Scn10a
promoter-EGFP construct expression. Positive marker for successful nuclear injections, dsRed2nuc, shown on the right. Eii, The number of positive cells, expressed as a percentage of total neurons
injected, and 95% confidence intervals are represented on graph. A total of 46 rat DRG neurons (from 4 different animals) and 103 rat nodose neurons (from 5 different animals) were injected. The
proportion of injected neurons expressing EGFP was significantly different between both groups. ***p 0.001 (Fisher’s exact test). Unless otherwise stated: scale bar, 50m.
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somatosensory cortex, but not in the primary motor cortex, and
only a sparse number of bright EGFP-positive cells were found in
the globus pallidus. The largest and brightest cluster of EGFP-
positive cells was observed in the olfactory tubercle and hypothal-
amus, particularly in the rostral end, or peduncular part, of the
lateral hypothalamus and paraventricular nucleus. IHC staining
using antibodies against EGFP and Nav1.8 protein confirmed
EGFP expression in discrete brain regions and revealed cell bod-
ies positive for both proteins (Fig. 8A). However, not all EGFP-
positive cells were coimmunoreactive to Nav1.8. In addition, low
EGFP-IR was observed in the mitral cell layer of the olfactory
bulb, periaqueductal gray, and islands of Calleja in the ventral
striatum but did not correlate with Nav1.8-IR (data not shown).
To corroborate IHC results, Nav1.8 transcript was probed in
tissue samples from Scn10a-EGFP mice. Scn10a and control
-actin transcripts were amplified by conventional RT-PCR to
produce amplicons 742 and 500 bp in size, respectively, and re-
solved using agarose gel electrophoresis. Faint bands, corre-
sponding to the predicted size of the Scn10a amplicon, were
observed for amygdala, brainstem, somatosensory cortex, hypo-
thalamus, olfactory tubercle, and superior cervical ganglion
(SCG) tissue samples compared with a dense band in the DRG
sample lane (Fig. 8B). A band corresponding to the -actin am-
plicon was observed with all tissue samples tested. No bands were
detected in DRG tissue amplified without reverse transcriptase
and the no template negative control (W, water). Quantitative
PCR analysis of a panel of brain and peripheral tissues was per-
formed to assess the relative abundance of Scn10a transcript. The
level of Scn10a transcript was highest in DRG tissues (Fig. 8C).
nodose tissue samples also expressed an abundant amount of
Scn10a transcript similar to DRG samples. Transcript was de-
tected, although significantly less, in amygdala, brainstem, globus
pallidus, hypothalamus, olfactory tubercle, and SCG tissue sam-
ples (p  0.01, one-way ANOVA with Holm-Sidak’s multiple-
comparisons test). Two samples of the globus pallidus and one
sample of SCG tissue did not produce amplification curves and
were excluded from analysis. Also, no amplification curves were
observed for primary motor cortex, somatosensory cortex, hip-
Figure 7. EGFP expression outside the nervous system of Scn10a-EGFP mice. A–E, Left, Phase-contrast images. Right, EGFP fluorescence images. A, Images from transverse sections of cardiac
ganglion (Ai) or cardiacmuscle (Aii) tissue.White arrowheads indicate EGFP-positive cells in both images.B, Testes.C, Eye.D, Pancreas.E, Kidney.F, Ectopic EGFP expression in epidermal skin layers.
Fi, Paw on the left from awild-typemouse; paw on the right from an EGFP-positive transgenic mouse. Fii, Thin footpad skin section from awild-typemouse. Fiii, Thin footpad skin section from an
EGFP-positive transgenicmouse.G, Grueneberg ganglion. Left, Low-magnification fluorescence image of an Scn10a-EGFPmouse nose. Phase-contrast (middle) and EGFP fluorescence (right) image
of a dissected Grueneberg ganglion from an Scn10a-EGFP mouse under higher magnification.
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pocampus, striatum, and thalamus samples as well as no reverse
transcriptase and no template-negative controls. The presence of
Scn10amRNA in SCG samples was confirmed in both transcript
assays, which was surprising because TTX-R INa have not been
observed in dissociated rat SCG neurons (Schofield and Ikeda,
1988). However, the close proximity of SCGs to petrosal and
nodose ganglia, both sensory ganglia that express Nav1.8, in mice
may facilitate fusion during development and lead to inadvertent
contamination of SCG samples.
Asmentioned previously, the EGFP fluorescence from cells in
the hypothalamus was bright enough to be visible in acutely pre-
pared brain slices (300 m thick; Fig. 8D), thus allowing identi-
fication of acutely dissociated neurons for electrophysiological
study (Fig. 8Ei). In 8 of 22 EGFP-positive hypothalamic neurons,
INawere recorded in the presence of 3MTTX (mean TTX-R INa
amplitude37.6
 7.2 pA, n 8), which could be blocked by
the Nav1.8 selective blocker A-803467 (3 M, 4 of 4 cells tested;
Fig. 8Eii). A-803467 also blocks low voltage-activatedCa2 chan-
nels (Bladen and Zamponi, 2012); however, we are fairly confi-
dent the currents blocked in dissociated hypothalamic neurons
are from Nav1.8 channels for two reasons. First, our external
recording solution contained Mg2 (10 mM), which is imper-
meant and blocks inward currents carried bymonovalent cations
through voltage-gated Ca2 channels (Fukushima and Hagi-
wara, 1985). Second, the concentration of A-803467 used (3M)
was near the plateau for 100% inhibition of TTX-R INa (Jarvis et
al., 2007) but is approximately the IC50 for A-803467 block of low
voltage-activated ICa. We observed complete block of TTX-R INa
Figure8. EGFP expression in discrete regions of the CNS of Scn10a-EGFPmice.A, IHC of various brain regions. First rowpanels represent low-magnification (20/0.30NAobjective) fluorescence
imagesobtained fromtheEGFP channel. Scalebar, 50m.Remaining imagesarehigher-magnification (63/1.2NAobjective) fluorescent images fromtheEGFP channel (second row), red channel
(third row), or merged images from both fluorescence channels pseudo-colored green and purple (fourth row). Scale bar, 10m for images obtained at higher magnification. B, Conventional
RT-PCR analysis ofmRNA encoding Scn10a and-actin inmultiple brain regions and peripheral ganglia. Based on the primer sets used, the predicted sizes of the Scn10a and-actin amplicons are
742 and 500 bp, respectively. The resultant PCR products were separated and visualized on a 1.5% agarose gel. A, Amygdala; B, brainstem; CM, primary motor cortex; CS, somatosensory cortex; G,
globus pallidus; Hi, hippocampus; Hy, hypothalamus; O, olfactory tubercle; S, striatum; T, thalamus; D, DRG; SCG, superior cervical ganglia; ND, nodose ganglia; W, water; L, ladder. C, Expression of
Scn10a transcript across various brain regions and peripheral ganglia as assessed by qPCR. Relative expression of Scn10amRNA to DRG tissue was obtained from the formula 2		Ct (detailed in
Materials andMethods). Dotted line indicatesmean normalized expression level in DRG neurons (2		Ct 1). Each point indicates a biological replicate.Means are represented as bars. Error bars
indicate SEM. The differences between mean 2		Ct values for all regions with DRGs were statistically significant, except for nodose ( p 0.01, one-way ANOVA with Holm-Sidak’s multiple-
comparisons test).D, Acutely prepared coronal brain slice under fluorescence optics. Hypothalamic regionmagnified to the right.Ei, Acutely dissociated hypothalamic neurons under phase-contrast
(above) or EGFP fluorescence (below). Eii, Sample electrophysiological recording froman EGFP-positive dissociated hypothalamic neuron. Black trace represents INa recorded in the presence of 3M
TTX. Red trace represents INa recorded in the presence of 3M TTX and 3M A-803467 drug. Four consecutive current traces for each condition were averaged and represented.
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in dissociated hypothalamic neurons tested with 3 M A-803467
(Fig. 8Eii).
To our knowledge, this is the first demonstration of TTX-R
INa recordings from central neurons thought to arise from
Nav1.8. As the TTX-R INa recorded fromEGFP-positive hypotha-
lamic neurons of transgenic mice accounted for only 1.6
 0.3%
(n  8) of the total INa, it seems unlikely that Nav1.8 channels
make a major contribution to normal neuronal activity in these
neurons. However, the role of Nav1.8 in CNS excitability may be
larger under pathological conditions. Other studies have demon-
strated upregulated Nav1.8-IR in cerebellar Purkinje neurons of
patients diagnosed with multiple sclerosis (Shields et al., 2012b)
and in an animal model of multiple sclerosis (Black et al., 2000;
Damarjian et al., 2004).
Discussion
We have previously identified a fragment of genomic DNA up-
stream of the Scn10a gene, which drives EGFP reporter expres-
sion in a subpopulation of DRG neurons within primary cultures
but not in select cell lines or sympathetic and central neurons
(Puhl and Ikeda, 2008). This reporter construct has been used by
others to identify putative nociceptive neurons in rat DRG prep-
arations for further study (Hassan and Ruiz-Velasco, 2013; Has-
san et al., 2014). Here, we characterize a transgenic mouse line
generated from this same reporter cassette that confirms and
expands our previous in vitro findings. An Scn10a reportermouse
line, such as the one detailed in this study, will allow identifica-
tion of the Nav1.8-expressing population of sensory neurons.
Furthermore, our transgenic reporter mouse is amendable to
functional studies, as it does not involve inactivation of the
Scn10a gene, and offers temporal resolution of Nav1.8 expression
unavailable in Cre-recombinase-based reporter systems.
Characterization of any transgenic line is very important for
their utility.Hence, we carefully investigated the EGFP transgenic
reporter expression pattern and its correlation with Scn10ames-
sage and gene product, Nav1.8. The expression of Nav1.8 chan-
nels is mainly restricted to primary sensory neurons, and in
Scn10a-EGFP mice, EGFP expression was most prominent in a
subset of DRG neuron somata (Fig. 1B). The majority of EGFP-
positive cells were small- to medium-sized, nonpeptidergic neu-
rons that bound IB4 (Fig. 5B,C; Table 1), whereas a small
proportion (8%–10%) were medium- to large-diameter myelin-
ated A-fiber neurons as denoted by colabeling with CtB and
NF200 (Table 1). This result is in agreement with other studies
characterizing the Nav1.8-expressing population of DRG neu-
rons in rats (Amaya et al., 2000; Ramachandra et al., 2013) and
Nav1.8-Cre mice (Agarwal et al., 2004; Shields et al., 2012a). A
population of small-diameter DRG neurons also expressed
EGFP, including a fraction that colabeled with markers of pepti-
dergic neurons, CGRP and Substance P, and TH. Recent work
suggests that TH is exclusively expressed in a population of un-
myelinated low-threshold mechanoreceptor C-fiber neurons
(Usoskin et al., 2015), and this population of neurons is respon-
sive to cold stimuli (Seal et al., 2009). Interestingly, Nav1.8 chan-
nels are the only voltage-gated sodium channels that remain
functional at cold temperatures and are responsible for action
potential generation in response to noxious cold (Zimmermann
et al., 2007). EGFP expression in the outer and inner Lamina II of
the spinal dorsal horn, where IB4 binding and low-threshold
mechanoreceptor C-fibers, respectively, terminate, supports
Nav1.8 expression in these DRG neuronal populations.
Expression of EGFP in DRG neurons of transgenic mice cor-
related well with the presence of Nav1.8 transcript (Figs. 2, 8C)
and protein (Fig. 3; Table 1). In terms of functional Nav1.8 pro-
tein, EGFP-positive DRG neurons from transgenic mice display
sodium currents in the presence of TTX with kinetic and bio-
physical properties similar to those attributed to Nav1.8 channels
(Fig. 4; Table 2). TTX-R INa have been described in C-type sen-
sory neurons as well as in some A and high-threshold A neu-
rons (Shields et al., 2012a; Ramachandra et al., 2013). Glial
cell-derived neurotrophic factor and nerve growth factor main-
tains EGFP expression in DRG neurons of Scn10a-EGFP mice
(Fig. 5A), which is consistent with the influence growth factors
have on themagnitude of TTX-R INa in DRGneurons (Fjell et al.,
1999a, b; Leffler and Cummins, 2002). The correlation between
EGFP expression andNav1.8-IRwas high (80%ofNav1.8-IR cells
were also EGFP-positive) but not absolute. Overall, the Scn10a-
EGFP mice generated and characterized in this study serve as a
good reporter of Nav1.8 expression in peripheral sensory neu-
rons. The promoter regionwe previously identified and validated
in vitro (Puhl and Ikeda, 2008) recapitulates most Nav1.8 expres-
sion in vivo.
Failure of EGFP expression in Nav1.8 expressing cells (i.e.,
false negatives)might suggest the involvement of other promoter
elements beyond the 3.7 kb genomic fragment used to generate
transgenic mice. Further supporting this notion, several cranial
sensory ganglia in Scn10a-EGFPmice failed to express EGFP (Fig.
6A–D). Neuronal cell bodies within the caudal portion of the
nodose ganglion lacked an EGFP signal (Fig. 6A) despite express-
ing Nav1.8 transcript (Fig. 8C) and protein (Fig. 6Aiii; Table 1).
Moreover, EGFP was absent in the nucleus of the solitary tract
and area postrema, brainstem regions that receive inputs from
visceral afferents originating fromnodose ganglion neurons. This
lack of reporter gene expression was in contrast to findings from
theNav1.8-Cre reportermouse (Gautron et al., 2011) andwas not
a positional artifact of transgenicmouse generation (i.e., random
insertion into genome) because acute expression of the same
transgene construct recapitulated the absence of transgene ex-
pression in dissociated rat nodose neurons (Fig. 6E). In contrast,
the jugular ganglion, located immediately rostral to the nodose
ganglion, expressed an abundance of EGFP in neuronal cell bod-
ies (Fig. 6Aii). The jugular ganglion,which forms a fused complex
with the nodose ganglion in mice, develops from the neural crest
as opposed to the nodose ganglion, which arises from epibran-
chial placodes. A reporter mouse line that labels neurons origi-
nating from the neural crest (Wnt1-Cre) exhibits a similar
pattern of expression as EGFP in the jugular-nodose ganglia
complex of our transgenic mice (Nassenstein et al., 2010), thus
supporting our conclusion that the 3.7 kb promoter fragment
chosen to generate transgenic mice directs Scn10a expression in
neural crest but not placodal-derived sensory ganglion neurons.
We previously described two promoter modules within the
3.7 kb promoter fragment used here. Both modules, a proximal
neuron specific module and a distal sensory neuron restrictive
module, are required to produce the highly restrictive expression
pattern of Scn10a. Elimination of the distal module alleviates the
sensory neuron restrictive expression of Scn10a to allow reporter
expression in peripheral sympathetic neurons and a neuroblas-
toma cell line (Puhl and Ikeda, 2008). Based on our current study,
the mechanism restricting transgene expression in neural crest-
derived neurons of transgenic mice appears to involve these two
modules; however, additional elements or modules may be nec-
essary to expand endogenous Scn10a expression in placodal-
derived neurons. This idea is not without precedence as a similar
promoter organization has been found for the rat TH gene. In
that case, a proximal 4.5 kb promoter region drove expression in
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CNS neurons and an additional 4.5 kb distal region upstream
expanded expression and directed a more canonical expression
pattern in central and peripheral sympathetic catecholaminergic
neurons (Schimmel et al., 1999; Gelman et al., 2003).
Alternatively, a second promoter for the Scn10a gene respon-
sible for expression in placodal-derived neurons is also possible.
The Scn5a gene, a genomic neighbor of the Scn10a gene that
encodes the TTX-R voltage-gated sodium channel Nav1.5, has
been shown to contain multiple promoters operating at distinct
developmental stages (Shang andDudley, 2005). Identification of
the specific promoter or additional promoter elements responsi-
ble for Scn10a expression in placodal-derived neurons may be
useful in selectively targeting cranial neurons responsible for gus-
tatory and viscerosensory functions rather than neurons that
convey somatosensory information. We are also using the
Scn10a-EGFP mouse as a tool to identify neural crest-specific
proteins or transcription factors that may be responsible for the
restrictive expression pattern of Nav1.8 in peripheral sensory
neurons. Studies into additional promoter regions or promoter
elements of the Scn10a gene are ongoing.
In summary, we have extended our previous in vitro charac-
terization of a 3.7 kb promoter region controlling expression of
the Scn10a gene by creating a transgenic mouse line. Our main
findings include the following: (1) The incorporation of the 3.7
kb reporter cassette supported our previous findings of expres-
sion in a subset of sensory neurons of the DRG and a lack of
expression in sympathetic neurons. (2) The 3.7 kb genomic re-
gion produced selective reporter expression in neurons of neural
crest-derived sensory ganglia but not in sensory neurons from
ganglia of placodal decent. (3) In addition to thesemain findings,
we have also documented reporter expression in a variety of novel
peripheral and central locations andused this reporter expression
to isolate some of these neurons for further studies. These exper-
iments have not only shown coincidental expression of Scn10a
transcript with reporter EGFP but have also allowed for the func-
tional identification of the TTX-R INa in these neurons, thus
exemplifying the utility of this reporter mouse line as a tool to
study expression of Nav1.8 in select locations. Expanding upon
this idea, these mice may also serve as a valuable resource to
facilitate the identification and hence the study of nociceptive
neurons as well as the effects of various environmental and path-
ological states on the expression of the transgene and therefore
the Scn10a gene.
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